The main aim of this study is to determine the positive predictive value of combined mp-MRI and PSMA PET/CT imaging and to determine the added value of targeted biopsies in the clinical workup towards focal salvage treatment of locally recurrent prostate cancer. This evidence concerns the gene FOLH1 and prostate carcinoma.